UB Paderborn / Katalog / Suche / in CDI

Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years

Blood, 2018-05, Vol.131 (22), p.2475-2484

2018

Volltextzugriff (PDF)

A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia

Clinical cancer research, 2018-12, Vol.24 (24), p.6185-6194

2018

Volltextzugriff (PDF)

Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia

Pediatric blood & cancer, 2018-10, Vol.65 (10), p.e27300-n/a

2018

Volltextzugriff (PDF)

Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in Sweden: a comparison between a pediatric protocol and an adult protocol

Cancer, 2006-10, Vol.107 (7), p.1551-1561

2006

Volltextzugriff (PDF)

Impact of body mass index on outcome and treatment-related toxicity in young adults with acute lymphoblastic leukemia

Acta oncologica, 2023, Vol.62 (12), p.1723-1731

2023

Volltextzugriff (PDF)

A Study Protocol for Validation and Implementation of Whole-Genome and -Transcriptome Sequencing as a Comprehensive Precision Diagnostic Test in Acute Leukemias

Frontiers in medicine, 2022, Vol.9, p.842507-842507

2022

Volltextzugriff (PDF)

Survival in adult acute lymphoblastic leukaemia (ALL): A report from the Swedish ALL Registry

European journal of haematology, 2019-08, Vol.103 (2), p.88-98

2019

Volltextzugriff (PDF)

Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia

European journal of haematology, 2016-02, Vol.96 (2), p.160-169

2016

Volltextzugriff (PDF)

Ex vivo activity of cardiac glycosides in acute leukaemia

PloS one, 2011-01, Vol.6 (1), p.e15718

2011

Volltextzugriff (PDF)

Cytogenetic aberrations in adult acute lymphoblastic leukemia—A population‐based study

EJHaem, 2021-11, Vol.2 (4), p.813-817

2021

Volltextzugriff (PDF)

Hematopoietic Stem Cell Transplantation Rates and Long-Term Survival in Acute Myeloid and Lymphoblastic Leukemia: Real-World Population-Based Data From the Swedish Acute Leukemia Registry 1997-2006

Cancer, 2011-09, Vol.117 (18), p.4238-4246

2011

Volltextzugriff (PDF)

Real-world data on first relapse of acute lymphoblastic leukemia in patients >55 years

Leukemia & lymphoma, 2018-10, Vol.59 (10), p.2470-2473

2018

Volltextzugriff (PDF)

High curability via intensive reinduction chemotherapy and stem cell transplantation in young adults with relapsed acute lymphoblastic leukemia in Sweden 2003–2007

Haematologica (Roma), 2012-09, Vol.97 (9), p.1414-1421

2012

Volltextzugriff (PDF)

Real-world data on first relapse of acute lymphoblastic leukemia in patients > 55 years

Leukemia & lymphoma, 2018, Vol.59 (10), p.2470

2018

Volltextzugriff (PDF)

Third Generation CD19-CAR T Cells for Relapsed and Refractory Lymphoma and Leukemia Report from the Swedish Phase I/IIa Trial

Blood, 2015-12, Vol.126 (23), p.1534-1534

2015

Volltextzugriff (PDF)

The prophylactic use of granulocyte-colony stimulating factor during remission induction is associated with increased leukaemia-free survival of adults with acute lymphoblastic leukaemia: A joint analysis of five randomised trials on behalf of the EWALL

European journal of cancer (1990), 2012-02, Vol.48 (3), p.360-367

2012

Volltextzugriff (PDF)

Invasive fungal infection by Peziza ostracoderma in an immunocompromised patient

Medical mycology case reports, 2023-03, Vol.39, p.26-30

2023

Volltextzugriff (PDF)

Do Deletions in 9p Reflect Prognosis in Adult Precursor B-Cell ALL? a Multi-Centre Study of 381 Patients

Blood, 2008-11, Vol.112 (11), p.4865-4865

2008

Volltextzugriff (PDF)

High relapse rate of T cell acute lymphoblastic leukemia in adults treated with Hyper-CVAD chemotherapy in Sweden

European journal of haematology, 2014, Vol.92 (5), p.377-381

2014

Volltextzugriff (PDF)

Age but not Philadelphia positivity impairs outcome in older/elderly patients with acute lymphoblastic leukemia in Sweden

European journal of haematology, 2017-08, Vol.99 (2), p.141-149

2017

Volltextzugriff (PDF)

Introducing patient‐reported outcome in the acute leukemia quality registries in Sweden

European journal of haematology, 2020-06, Vol.104 (6), p.571-580

2020

Volltextzugriff (PDF)

Long-term outcome of Epstein-Barr virus DNAemia and PTLD with the use of preemptive rituximab following allogeneic HSCT

Leukemia & lymphoma, 2018-05, Vol.59 (5), p.1172-1179

2018

Volltextzugriff (PDF)

Hematopoietic stem cell transplantation rates and long‐term survival in acute myeloid and lymphoblastic leukemia

Cancer, 2011-09, Vol.117 (18), p.4238-4246

2011

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years

A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia

Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia

Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in Sweden: a comparison between a pediatric protocol and an adult protocol

Impact of body mass index on outcome and treatment-related toxicity in young adults with acute lymphoblastic leukemia

A Study Protocol for Validation and Implementation of Whole-Genome and -Transcriptome Sequencing as a Comprehensive Precision Diagnostic Test in Acute Leukemias

Survival in adult acute lymphoblastic leukaemia (ALL): A report from the Swedish ALL Registry

Cerebral sinovenous thrombosis and asparaginase re‐exposure in patients aged 1–45 years with acute lymphoblastic leukaemia: A NOPHO ALL2008 study

Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia

Ex vivo activity of cardiac glycosides in acute leukaemia

Cytogenetic aberrations in adult acute lymphoblastic leukemia—A population‐based study

Hematopoietic Stem Cell Transplantation Rates and Long-Term Survival in Acute Myeloid and Lymphoblastic Leukemia: Real-World Population-Based Data From the Swedish Acute Leukemia Registry 1997-2006

P506: CLINICAL VALIDATION OF THE NORDIC GUIDELINES FOR GERMLINE TESTING IN MYELOID NEOPLASMS: RESULTS FROM A MULTI‐CENTER PROSPECTIVE COHORT STUDY

Real-world data on first relapse of acute lymphoblastic leukemia in patients >55 years

High curability via intensive reinduction chemotherapy and stem cell transplantation in young adults with relapsed acute lymphoblastic leukemia in Sweden 2003–2007

Real-world data on first relapse of acute lymphoblastic leukemia in patients > 55 years

Third Generation CD19-CAR T Cells for Relapsed and Refractory Lymphoma and Leukemia Report from the Swedish Phase I/IIa Trial

The prophylactic use of granulocyte-colony stimulating factor during remission induction is associated with increased leukaemia-free survival of adults with acute lymphoblastic leukaemia: A joint analysis of five randomised trials on behalf of the EWALL

Invasive fungal infection by Peziza ostracoderma in an immunocompromised patient

Do Deletions in 9p Reflect Prognosis in Adult Precursor B-Cell ALL? a Multi-Centre Study of 381 Patients

High relapse rate of T cell acute lymphoblastic leukemia in adults treated with Hyper-CVAD chemotherapy in Sweden

Age but not Philadelphia positivity impairs outcome in older/elderly patients with acute lymphoblastic leukemia in Sweden

Introducing patient‐reported outcome in the acute leukemia quality registries in Sweden

Long-term outcome of Epstein-Barr virus DNAemia and PTLD with the use of preemptive rituximab following allogeneic HSCT

Hematopoietic stem cell transplantation rates and long‐term survival in acute myeloid and lymphoblastic leukemia

Aktive Filter

Suchergebnisse filtern